Literature DB >> 3325935

The use of fluoroquinolones in chronic otitis suppurativa.

P H van de Heyning1, S R Pattyn, H D Valcke, D L van Caekenberghe, J Claes.   

Abstract

The present review covers fluoroquinolone usage in chronic otitis suppurativa (COS) in case of chronic otitis media, cholesteatoma, radical mastoid cavity infection and chronic or relapsing otitis externa. A total of six publications were included in the final evaluation. Enoxacin was effective in 35%; ciprofloxacin (five publications) was used in 82 patients with 67% effectivity in otitis externa and otitis media and 61% effectivity in radical mastoid cavity infection. No serious adverse reactions were reported. The promising efficacy of otitis media and otitis externa and safety profile needs further confirmation in double blind prospective clinical studies, that will provide a firm basis for changing the current treatment schedules of COS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3325935     DOI: 10.1007/bf02075270

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  16 in total

1.  Single and multiple dose pharmacokinetics of ciprofloxacin.

Authors:  U Ullmann; W Giebel; A Dalhoff; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

Review 2.  Otitis media in children: to treat or not to treat?

Authors:  C D Bluestone
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

3.  Cholesteatoma or keratoma, "a pathological approach".

Authors:  J Marquet; P H Van de Heyning
Journal:  J Belge Radiol       Date:  1980

4.  Otitis media in children: a prospective study of aerobic and anaerobic bacteriology.

Authors:  I Brook
Journal:  Laryngoscope       Date:  1979-06       Impact factor: 3.325

5.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph.

Authors:  T Harada; M Iwamori; Y Nagai; Y Nomura
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jul-Aug       Impact factor: 1.547

7.  Acute otitis externa in divers working in the North Sea: a microbiological survey of seven saturation dives.

Authors:  S R Alcock
Journal:  J Hyg (Lond)       Date:  1977-06

8.  Topical therapeutics for otitis media.

Authors:  D N Fairbanks
Journal:  Otolaryngol Head Neck Surg       Date:  1981 May-Jun       Impact factor: 3.497

9.  Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.

Authors:  A M Lerner; M P Reyes; L A Cone; D C Blair; W Jansen; G E Wright; R R Lorber
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

10.  Ciprofloxacin in oral treatment of ear infections.

Authors:  P H Van de Heyning; S R Pattyn; H D Valcke
Journal:  Pharm Weekbl Sci       Date:  1986-02-21
View more
  1 in total

Review 1.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.